Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes
about
Chemotherapy-induced neuropathies-a growing problem for patients and health care providersPathophysiology of Chemotherapy-Induced Peripheral Neuropathy.Chemotherapy-induced peripheral neurotoxicity: management informed by pharmacogenetics.Axonal Transport Impairment in Chemotherapy-Induced Peripheral NeuropathyClinical and genetic predictors of paclitaxel neurotoxicity based on patient- versus clinician-reported incidence and severity of neurotoxicity in the ICON7 trial.
P2860
Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes
@ast
Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes
@en
type
label
Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes
@ast
Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes
@en
prefLabel
Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes
@ast
Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes
@en
P2093
P2860
P356
P1433
P1476
Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes
@en
P2093
Clement T Loy
Craig R Lewis
John B Kwok
Matthew C Kiernan
Michael L Friedlander
Susanna B Park
P2860
P2888
P356
10.1186/1471-2407-14-993
P407
P577
2014-12-22T00:00:00Z
P5875
P6179
1047676349